Adcetris (brentuximab vedotin)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Adcetris (brentuximab vedotin), covering 2017-01-19 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma [Phase 2]